This study illuminated the molecular mechanism of CEACAM5 in intestinal barrier dysfunction induced by SARS-Cov-2 spike, providing potential therapeutic strategies to alleviate intestinal barrier damage in severe COVID-19 patients. Here, CEACAM5 is linked to COVID-19.